Alnylam Pharmaceuticals ALNY
NASDAQ ALNY
$227.28 +2.18 (+0.97%)
At close: Oct 22, 2026 · 4:00 PM EDT

Alnylam Pharmaceuticals (ALNY) Land & Improvements (2016 - 2018)

Updated

Alnylam Pharmaceuticals (ALNY) recorded Land & Improvements of $9.08 million in Q4 2018, unchanged from $9.08 million a year earlier.

Analysis

Alnylam Pharmaceuticals (ALNY) Land & Improvements (2016 - 2018) Analysis & Trends

  • Across earlier years, Land & Improvements came in at $9.08 million in FY2017 (unchanged) and $9.08 million in FY2016.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Land & Improvements (Qtr)
1 Eli Lilly 1,165.22 Bn 1,133.81 Bn 19.71 Bn -
2 Johnson & Johnson 646.28 Bn 566.14 Bn 17.30 Bn -
3 AbbVie 503.17 Bn 476.28 Bn 12.70 Bn -
4 Merck 365.23 Bn 319.60 Bn 12.21 Bn -
5 Novartis Ag 302.66 Bn 266.65 Bn 11.24 Bn -
6 Astrazeneca 267.39 Bn 241.08 Bn 12.86 Bn -
7 Amgen 241.61 Bn 197.01 Bn 7.24 Bn -
8 Gilead Sciences 194.67 Bn 168.86 Bn 6.22 Bn -
9 Pfizer 172.91 Bn 119.55 Bn 10.94 Bn -
10 Alnylam Pharmaceuticals 30.17 Bn 18.22 Bn 992.69 Mn -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2018 9.08 Mn
Dec 31, 2017 9.08 Mn
Dec 31, 2016 9.08 Mn
API Access

Alnylam Pharmaceuticals Land & Improvements API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=land-and-improvements&ticker=ALNY&period=max&api_key=YOUR_API_KEY